These results indicate that the cytotoxicity of Ad.DD3.D55-PTEN was not only much stronger than that of Ad.DD3.D55 due to the expression of PTEN, but was also highly restricted to prostate cancer cells. Here, PTEN is linked to prostate carcinoma.